Feasibility of Telerehabilitation in HIV-patients
Feasibility and Benefit of a Telerehabilitation Program in Human Immunodeficiency Virus-infected Patients
The aim of this study is to assess the feasibility and the effects of a 6-week telerehabilitation on the three domains of the International Classification of Functioning, Disability and Health in HIV-infected patients under highly active antiretroviral therapy (HAART).
HIV-infected patients were randomized either into an Endurance and Resistance Training Exercise (ERTE) group or a control (CON) group. Telerehabilitation was realized in a public fitness center, with online guidance and weekly telephone advice, 3 times per week for 6 weeks. Feasibility was determined by recruitment rate, retention rate and adverse events. Secondary outcomes were impact on body composition, inflammation and coagulation (C-reactive protein, D-dimer), physical fitness and quality of life (WHOQOL-HIV).
Studieöversikt
Status
Status
Betingelser
Betingelser
Intervention / Behandling
Intervention / Behandling
Studietyp
Studietyp
Inskrivning (Faktisk)
Inskrivning
Fas
Fas
- Inte tillämpbar
Deltagandekriterier
Urvalskriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- 18 years or older
- under HAART treatment
- native French speaker
Exclusion Criteria:
- AIDS diagnosis
- physical and/or psychiatric impairments that seriously impaired physical activity
- pregnant
- Unstable (defined by any modification of health outcomes during the last 6 months).
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Behandling
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Ingen (Open Label)
Antal vapen
Vapen och interventioner
Deltagargrupp / ArmDeltagargrupp / Arm |
Intervention / BehandlingIntervention / Behandling |
|---|---|
|
Inget ingripande: Kontrollgrupp
Vanlig skötsel
|
|
|
Experimentell: Endurance and Resistance Training Exercise
|
Patients received a 6-week tele-supervised rehabilitation with 3 exercise sessions per week
|
Vad mäter studien?
Primära resultatmått
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Recruitment rate
Tidsram: At study completion (after 6 weeks)
|
Number of eligible participants who enrolled in the program out of the number were recruited
|
At study completion (after 6 weeks)
|
|
Retention rate
Tidsram: At study completion (after 6 weeks)
|
Percentage of patients lost to follow-up
|
At study completion (after 6 weeks)
|
|
Adverse events
Tidsram: At study completion (after 6 weeks)
|
Percentage of patients who experienced one or more adverse events
|
At study completion (after 6 weeks)
|
Sekundära resultatmått
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Weight
Tidsram: Assessments at baseline and at 6 weeks
|
Weight (kg) is measured by using a bioelectrical impedance analysis
|
Assessments at baseline and at 6 weeks
|
|
Lean body mass
Tidsram: Assessments at baseline and at 6 weeks
|
Lean body mass (kg) is measured by using a bioelectrical impedance analysis
|
Assessments at baseline and at 6 weeks
|
|
Fat body mass
Tidsram: Assessments at baseline and at 6 weeks
|
Lean body mass (kg) is measured by using a bioelectrical impedance analysis
|
Assessments at baseline and at 6 weeks
|
|
C-reactive protein
Tidsram: Assessments at baseline and at 12 weeks
|
C-reactive protein is measured by a blood test
|
Assessments at baseline and at 12 weeks
|
|
D-dimer
Tidsram: Assessments at baseline and at 12 weeks
|
D-dimer is measured by a blood test
|
Assessments at baseline and at 12 weeks
|
|
CD4+ T cell counts
Tidsram: Assessments at baseline and at 12 weeks
|
CD4+ T cell counts is measured by a blood test
|
Assessments at baseline and at 12 weeks
|
|
Viral load
Tidsram: Assessments at baseline and at 12 weeks
|
Viral load is measured by a blood test
|
Assessments at baseline and at 12 weeks
|
|
Functional exercise capacity
Tidsram: Assessments at baseline and at 6 weeks
|
Functional exercise capacity is measured by a 6-minute walk test
|
Assessments at baseline and at 6 weeks
|
|
Flexibility
Tidsram: Assessments at baseline and at 6 weeks
|
Flexibility is measured by Toe touch test and sit and reach test
|
Assessments at baseline and at 6 weeks
|
|
Lower body muscular strength
Tidsram: Assessments at baseline and at 6 weeks
|
Lower body muscular strength is measured by 30-s chair-stand test
|
Assessments at baseline and at 6 weeks
|
|
Upper limb strength
Tidsram: Assessments at baseline and at 6 weeks
|
Upper limb strength is measured by hand grip strength tool
|
Assessments at baseline and at 6 weeks
|
|
Quality of life
Tidsram: Assessments at baseline and at 6 weeks
|
Quality of life is measured by World Health Organization Quality of Life HIV Instrument
|
Assessments at baseline and at 6 weeks
|
Samarbetspartners och utredare
Sponsor
Sponsor
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Studiestart
Primärt slutförande (Faktisk)
Primärt slutförande
Avslutad studie (Faktisk)
Avslutad studie
Studieregistreringsdatum
Först inskickad
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Första postat
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste uppdatering publicerad
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
- RNA-virusinfektioner
- Virussjukdomar
- Infektioner
- Blodburna infektioner
- Smittsamma sjukdomar
- Sexuellt överförbara sjukdomar, virala
- Sexuellt överförbara sjukdomar
- Lentivirusinfektioner
- Retroviridae-infektioner
- Immunsystemets sjukdomar
- Långsamma virussjukdomar
- HIV-infektioner
- Förvärvat immunbristsyndrom
- Immunologiska bristsyndrom
Andra studie-ID-nummer
Andra studie-ID-nummer
- Telerehabilitation HIV
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .